The DDB Public Hearings Committee in Session during the discussion on the inclusion of Gamma Butyro-Lactone (GBL) in the list of Dangerous Drugs - SPIK
Dangerous Drugs Board (DDB) Public Hearing on the Inclusion of Gamma Butyro Lactone (GBL) in the list of dangerous Drugs
DDB Public Hearings Committee , Gamma Butyro-Lactone, Dangerous Drugs
17037
post-template-default,single,single-post,postid-17037,single-format-standard,bridge-core-1.0.5,ajax_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,wpb-js-composer js-comp-ver-7.6,vc_responsive
DDB

The DDB Public Hearings Committee in Session during the discussion on the inclusion of Gamma Butyro-Lactone (GBL) in the list of Dangerous Drugs

Spread the love

Dangerous Drugs Board (DDB) Public Hearing on the Inclusion of Gamma Butyro Lactone (GBL) in the list of dangerous Drugs – February 6, 2017, DDB-PDEA Bldg., NIA Site, National Government Center, East Triangle, Q.C.